LLY80:BKK
Eli Lilly And Company KTB DR
1,98 THB
arrow_upward
+1,54%(+0,030) 1K
12-okt, 12:34:21 (GMT+7) · THB
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoLLY80 tikeri uchun statistika yaratilmoqda...
Ochish
1,98 THB
Yuqori
1,98 THB
Past
1,94 THB
Bozor kapitali
1,11 trln
Oʻrtacha hajm
5,19 mln
Hajmi
1,94 mln
52 haftalik eng yuqori
2,12 THB
52 haftalik eng past
1,27 THB
Muomaladagi aksiyalar
941,36 mln
Xodimlar soni
50 ming
Ochish
1,98 THB
Yuqori
1,98 THB
Past
1,94 THB
Bozor kapitali
1,11 trln
Oʻrtacha hajm
5,19 mln
Hajmi
1,94 mln
52 haftalik eng yuqori
2,12 THB
52 haftalik eng past
1,27 THB
Muomaladagi aksiyalar
941,36 mln
Xodimlar soni
50 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TipRanks
·
16 soat oldin
Eli Lilly (LLY) Stock: Why Taking Profits Could Make Sense Ahead of 2027
Investing.com Canada
·
1 kun oldin
Form 144 ELI LILLY AND COMPANY For: 11 October By Investing.com
Insider Monkey
·
1 kun oldin
Eli Lilly (LLY) Posted 48% Revenue Growth. Why Does the Stock Trade Below Its Average Multiple?
24/7 Wall St.
·
2 kun oldin
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
Profil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Eli Lilly And Company KTB DR haqida
CEODavid A. Ricks
Xodimlar soni50 ming
Asos solingan1876
Bosh ofislarIndianapolis, Indiana, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytlilly.com